The AI company rebuilding the plumbing of dental insurance - so payers, providers and patients all see the same number, at the same time.
There is a genre of company that no one photographs for a magazine cover, because its product is the removal of an annoyance. Retrace is one of those companies. It does not whiten teeth, straighten them, or livestream a root canal. It sits in the least glamorous room in dentistry - the one with the fax machine and the person whose entire job is arguing with insurers - and it tries to make that room disappear.
The premise is almost aggressively unsexy, which is usually a sign that someone has found real money. When a dentist proposes a crown, a filling, or an implant, a small clerical war begins. The office submits X-rays and notes. The insurer's system - or a human at the insurer - decides whether the procedure is covered, at what rate, and how much the patient owes. Then everyone waits. Claims can take weeks. Denials arrive for reasons that feel arbitrary. The patient, who has already been drilled, discovers the bill after the fact. It is a workflow apparently designed by someone who has never had a toothache.
Retrace's insight is the kind that sounds obvious once stated and took a decade to build: insurers have already approved millions of nearly identical claims. So why relitigate each one by hand? Feed the pattern to a model. The company's AI reads the X-ray and the clinical documentation, compares the proposed procedure against a vast library of previously adjudicated cases, and returns an answer in real time. When the patient sits down, the dentist already knows the payout and the patient already knows the out-of-pocket cost. The insurance money, in the version Retrace is selling, arrives immediately rather than eventually.
We built our AI from the ground up with the right infrastructure to incentivize providers in a simple way to deliver high-quality, evidence-based care to help patients.
The founder, Dr. Ali Sadat, is the reason this is credible rather than another slide deck. He holds a doctorate in dentistry from UC San Francisco and a bioengineering degree from UC San Diego, and before Retrace he held clinical and research appointments at UCSF and Zuckerberg San Francisco General Hospital. This is not a coder who read about dentistry; it is a dentist who can also train a model. That combination is the whole thesis. You cannot automate a workflow you have never personally suffered through, and Sadat has suffered through this one with a drill in his hand.
Nine or so people. Roughly $18 million. A network designed to touch every one of the 200,000-plus oral health providers in the United States. Small teams building infrastructure for large industries is one of the most leveraged shapes in technology, and Retrace is a clean example of it pointed at your molars.
The office submits X-rays and clinical documentation for a proposed procedure.
Retrace's AI checks the case against millions of previously approved claims.
Coverage, provider payout and patient out-of-pocket are known in real time.
Value-based payment flows to the provider, tied to quality - not just a code.
Real-time connectivity between payers, providers and patients, with 200+ external connections and reach to 200,000+ US oral health providers.
A natively-built AI clearinghouse and EDI gateway for dental claims - EHNAC/HNAP accredited for HIPAA-compliant health data transactions.
AI that reads imaging and records, validates the claim, and adjudicates against a library of approved cases - before the drill, not after.
Immediate provider payouts tied to provider and procedure quality ratings, with transparent patient cost from the start.
In 2021 Retrace stepped out of stealth as an Intel- and SoftBank-backed dental management network. It is worth pausing on who those backers are. Intel Capital and SoftBank Ventures Asia did not write checks for a flashy consumer app that whitens smiles on TikTok. They funded dental billing infrastructure. When patient, disciplined capital moves toward the least sexy corner of a market, that is usually a tell: the friction, and therefore the margin, is hiding in the paperwork.
The timing helped. The pandemic hammered dental practices - patient volumes collapsed, and the administrative overhead that had always been annoying became existential. A practice that waits three weeks for a claim, then eats a denial, is a practice with a cash-flow problem it cannot afford. Retrace's pitch of faster, more predictable collections landed in an industry that had suddenly become very interested in predictability.
Then, in 2022, Retrace did the unglamorous thing that actually matters in healthcare: it got accredited. The Electronic Healthcare Network Accreditation Commission granted it HNAP Electronic Health Network accreditation - the seal that says an organization can perform clearinghouse and EDI-gateway functions in compliance with HIPAA and industry standards. Retrace says it was the first dental AI company to clear that bar. In healthcare, trust is the product. You can have the best model in the world, but no payer will route a real claim through you until a third party has audited your privacy, security and uptime. The accreditation is less exciting than the AI and arguably more important to the business.
The interesting AI use case in medicine may not be diagnosis at all. It may be settling the bill.
That is the part worth sitting with. A great deal of medical-AI attention goes to diagnosis - spotting the tumor, reading the scan, catching what the human missed. Retrace pointed its models somewhere less romantic and, arguably, more tractable: claims. The ground truth in claims is clean - a claim was either approved or it wasn't - and the return on investment is measured in days-to-payment, a number every practice manager can feel. Retrace even published research probing "deep fakes" and adversarial manipulation in dental imaging, a reminder that when money rides on a picture of a tooth, someone will eventually try to fake the tooth.
There is also a soft, cultural thing buried in the mechanics. Retrace ties provider payment to quality ratings rather than to raw procedure codes. That is a small technical choice with a large incentive underneath it. Pay for outcomes instead of for volume, and you slowly change what an entire profession optimizes for. Whether that reshapes dentistry or merely nudges it is unknowable from the outside - but it is a more interesting ambition than "process claims faster," and it is the one Sadat keeps describing.
Dr. Ali Sadat starts the company in San Francisco with backing from friends and family.
Institutional venture capital arrives as Retrace builds out its AI infrastructure.
Emerges publicly as an Intel- and SoftBank-backed AI dental management network with 200+ connections.
First dental AI company to earn EHNAC clearinghouse accreditation; CEO named to Incisal Edge 40 Under 40.
Retrace is an AI-powered dental clearinghouse and network that automates insurance claims, eligibility verification and payments, connecting payers, providers and patients in real time.
Retrace Labs was founded in 2016 by Dr. Ali Sadat, a dentist and bioengineer, and is headquartered in San Francisco.
Roughly $18 million from investors including Intel Capital, SoftBank Ventures Asia and Stone Point Capital.
It reads X-rays and clinical documentation for a proposed procedure and compares them against millions of previously approved claims, so payout and patient cost are known in real time.
It was the first dental AI company to earn EHNAC HNAP Electronic Health Network accreditation, meeting HIPAA and industry standards for clearinghouse functions.